About the Authors
- Lingyi Fu
-
Affiliation State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
- Wangbing Chen
-
Affiliation State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
- Wei Guo
-
Affiliation Institute of Cancer Stem Cell, Dalian medical University Cancer Center, Dalian, China
- Jingshu Wang
-
Affiliation State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
- Yun Tian
-
Affiliation State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
- Dingbo Shi
-
Affiliation State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
- Xiaohong Zhang
-
Affiliation Institute of Cancer Stem Cell, Dalian medical University Cancer Center, Dalian, China
- Huijuan Qiu
-
Affiliation State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
- Xiangsheng Xiao
-
Affiliation State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
- Tiebang Kang
-
Affiliation State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
- Wenlin Huang
-
Affiliations State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China, State Key Laboratory of Targeted Drug for Tumors of Guangdong Province, Guangzhou Double Bioproduct Inc., Guangzhou, China
- Shusen Wang
-
* E-mail: dengwg@sysucc.org.cn (WD)wangshs@sysucc.org.cn (SW)
Affiliation State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
- Wuguo Deng
-
* E-mail: dengwg@sysucc.org.cn (WD)wangshs@sysucc.org.cn (SW)
Affiliations State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China, Institute of Cancer Stem Cell, Dalian medical University Cancer Center, Dalian, China, State Key Laboratory of Targeted Drug for Tumors of Guangdong Province, Guangzhou Double Bioproduct Inc., Guangzhou, China
Competing Interests
The authors declared the affiliation(s) to "Guangzhou Double Bioproduct Inc" in the Competing Interests section of the online manuscript form. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: LF WD. Performed the experiments: LF WC JW YT DS XZ WG HQ XX. Analyzed the data: LF SW XX. Contributed reagents/materials/analysis tools: TK WH. Wrote the manuscript: LF WD.